Trials / Completed
CompletedNCT02350023
Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata
A Randomized Comparative Study of Efficacy and Safety of Topical Latanoprost Versus Topical Corticosteroid in the Treatment of Localized Alopecia Areata
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Post Graduate Institute of Medical Education and Research, Chandigarh · Academic / Other
- Sex
- All
- Age
- 99 Years
- Healthy volunteers
- Not accepted
Summary
Alopecia areata (AA) is an autoimmune disease that involves the hair follicles. Topical corticosteroids are the established agents for treating this disorder. There are several case reports and case series which have demonstrated the efficacy of topical prostaglandins. The two agents have not been compared head-to-head in the published literature. The investigators attempt to compare the efficacy and safety of topical betamethasone and topical latanoprost in the treatment of localised alopecia areata.
Detailed description
Alopecia areata (AA) is an autoimmune disease that involves the hair follicles. Topical corticosteroids are the established agents for treating this disorder. Topical prostaglandins like latanoprost have also been used for this disorder. There are several case reports and case series which have demonstrated the efficacy of topical prostaglandins. However, the two agents i.e. topical corticosteroids and topical latanoprost have not been compared head-to-head in the published literature. The investigators attempt to compare the efficacy and safety of topical betamethasone and topical latanoprost in the treatment of localised alopecia areata.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topical latanoprost 0.005% | Local application of the drug on affected skin/scalp |
| DRUG | Topical betamethasone 0.05% | Local application of the drug on affected skin/scalp |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2015-01-29
- Last updated
- 2015-12-02
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02350023. Inclusion in this directory is not an endorsement.